Börse Express – ROUNDUP / Aktien New York: I hope that the corona vaccine based on

More positive news about the fight against the coronavirus pandemic gave Wall Street new impetus on Monday. Positive economic data also ensured a good mood.

Der Dow Jones Industrial It was unable to maintain its initial gains, but recently claimed a 0.56 percent increase to 29,427.62 points. The US benchmark thus partially offset Friday’s setback. For the S&P 500 of the entire market
It was up 0.07 percent to 3,560.02 points, while the equally friendly Nasdaq 100 started out tech heavy. 0.64 percent to 11,830.50 points.

The mood of US companies improved significantly in November despite the high number of corona infections, while analysts expected a deterioration. This was confirmed by the purchasing managers index produced by the research company Markit.

The one from Biontech and Pfizer
According to a government representative, the corona vaccine developed in the US could be available from December 11 in case of emergency approval. The vaccine could be delivered to states within 24 hours of approval by the US FDA, a representative responsible for the US government’s vaccination program told CNN.Biontech’s papers went up in New York up 0.8 percent, while Pfizer shares, initially favorable to the market, fell 1.1 percent.

Curevac New York Listed Stock
increased by more than three percent after the biotech company with Wacker Chemie had signed a contract to produce a candidate vaccine against Corona.

With the British-Swedish pharmaceutical company Astrazeneca
Another company also presented data on a corona vaccine. The vaccine has an average effectiveness of 70 percent, the company announced based on interim results from a major testing phase. Unlike the Biontech and Pfizer preparation, the Astrazeneca vaccine can be transported and stored in the refrigerator at temperatures of two to eight degrees.

“Even if the effectiveness seems a bit lower overall than with mRNA vaccines, AZD1222 has a huge advantage: it is robust and easy to use, so to speak, the ‘worker bee’ among potentially available Covid-19 vaccines.” the Munich-based company explained. Infectiologist Clemens Wendtner. Axi analyst Stephen Innes called the Astrazeneca news a “big problem.” This would likely put industrialized countries in a position to immunize most risk groups against lung disease by spring 2021.

Regeneron Stock increased by 0.2 percent. The company’s antibody cocktail for the treatment of Covid-19 received emergency approval in the United States. This means that it can be used to treat patients twelve years and older who are at risk of developing severe Covid 19 symptoms. However, patients who are in the hospital or need oxygen cannot receive the drug.

At Merck & Co the share price fell half a percent after the drug company announced that it would take over OncoImmune for $ 425 million in cash. The company has an active ingredient for corona patients with severe infections in clinical trials and recently reported positive data.

Aviation stocks visibly benefited from the new Corona news: while American Airlines increased by more than four percent, it was for United Airlines
despite plans for a further capital increase by 2.8 percent today / g / men

 ISIN  US2605661048  US6311011026  US78378X1072

AXC0301 2020-11-23 / 17: 35

Copyright dpa-AFX Wirtschaftsnachrichten GmbH. All rights reserved. Redistribution, republication or permanent storage is not permitted without the express prior consent of dpa-AFX.